November 23, 2011 -- The BioIndustry Association (BIA) has appointed Glyn Edwards as its interim Chief Executive effective immediately.
Mr Edwards was previously Chief Executive Officer of Antisoma from 1998-2011. Prior to joining Antisoma he worked in a variety of business development roles in the biotech and healthcare industries. He was also a member of the BIA Board. Mr Edwards has a BSc in Biochemistry from Bristol University and an MSc in Economics from the London Business School.
Tim Edwards, BIA Chairman, said:
‘I am delighted that Glyn has been able to join the BIA at this time. Nigel Gaymond has left to pursue other opportunities and I thank him for his engagement with members and his contribution to the BIA over the past two years.
‘Glyn’s experience as a biotech CEO and a former BIA Board member will be valuable as we continue to develop the BIA.’
Glyn Edwards, BIA Chief Executive, added:
‘I am looking forward to working with BIA members, its Board and staff to help ensure that the UK’s life sciences sector is recognised not only here in the UK but also globally.’
For further information, please contact Robert Winder, Communications Manager, 020 7630 2191; mobile 07825 942 934.
A photograph of Glyn Edwards is available on request.
BioIndustry Association
Founded over 20 years ago at the infancy of biotechnology, the BioIndustry Association (BIA) is the trade association for innovative enterprises involved in UK bioscience. Members include emerging and more established bioscience companies; pharmaceutical companies; academic, research and philanthropic organisations; and service providers to the bioscience sector. The BIA represents the interests of its members to a broad section of stakeholders, from government and regulators to patient groups and the media. Our goal is to secure the UK’s position as a global hub and as the best location for innovative research and commercialisation, enabling our world-leading research base to deliver healthcare solutions that can truly make a difference to people’s lives. For further information, please go to www.bioindustry.org
